DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Anethole trithione
Anethole trithione
Specifications of Approved Drug Compound Library
Tanibirumab (CUI C3490677) Add to Cart
Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
Age-Related Decrease in Resilience Against Acute Redox Cycling Agents: Critical Role of Declining GSH-Dependent Detoxification Capacity
Age-Related Loss of Nrf2, a Novel Mechanism for the Potential
The Development of Novel Cysteine Cross-Linkers and Their Application Towards Neurodegenerative Disorders
(12) United States Patent (10) Patent No.: US 8,771,755 B2 Gojon-Romanillos Et Al
Uncovering Active Modulators of Native Macroautophagy Through
Classification of Medicinal Drugs and Driving: Co-Ordination and Synthesis Report
ICCB-L Plate (10 Mm / 3.33 Mm) ICCB-L Well Vendor ID Chemical Name
Liste Positive Des Médicaments Valable Au 1Er Mai 2021 Cette Liste
National Licensed Medicine List of Afghanistan
Klasifikacija ATC 2019
Pharmacology and Toxicology
(12) United States Patent (10) Patent No.: US 8,414.914 B2 Bromley Et Al
Pharmaceutical Unit Dosage Form Comprising 4-Phenylbutyric Acid
(12) Patent Application Publication (10) Pub. No.: US 2015/0024048A1 Hemmingsen Et Al
List of Selected Drugs
Top View
Mesh Terms for 2002
(12) Patent Application Publication (10) Pub. No.: US 2017/0056347 A1 Glick Et Al
(12) United States Patent (10) Patent No.: US 9,642,809 B2 Hemmingsen Et Al
1 Supporting Information For: Inhibition of WTA Synthesis Blocks the Cooperative Action of Pbps and Sensitizes MRSA to ß- Lacta
(EDL) and a Licensed Drugs List (LDL) for Afghanistan
Metabolism of Anethole Dithiolethione by Rat and Human Liver Microsomes: Formation of Various Products Deriving from Its O-Demethylation and S-Oxidation
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
Klasifikacija ATC 2021
National Licensed Medicine List of Afghanistan
W O 2017/042267 A1 16 March 2017 (16.03.2017) W IPO I PCT
1908-Liste-Comm.Pdf
537.Full.Pdf
Drug Discovery Kits
ATC Code Title
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
Readingsample